Acquiring Company
Venmax Drugs & Pharmaceuticals
Acquired Company
Hatri Pharma Private Limited
HyderabadBiotechnologyHealth CarePharmaceuticalBiotechnologyHealth CarePharmaceuticalDescription
Venmax Drugs & Pharmaceuticals has scheduled a shareholder meeting on October 24, 2026, to discuss its proposed merger with Hatri Pharma Private Limited. The meeting follows an order from the National Company Law Tribunal, which supports the amalgamation process. This event marks a significant step in the regulatory approval journey for both companies. Stakeholders are encouraged to participate through remote means.
Don't miss Venmax Drugs & Pharmaceuticals's next move
Get an email the moment Venmax Drugs & Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Hatri Pharma Private Limited?
Hatri Pharma Private Limited was acquired by Venmax Drugs & Pharmaceuticals, based in Hyderabad. The deal was reported on September 8, 2026. Venmax Drugs & Pharmaceuticals is a leading company in the pharmaceutical sector. It specializes in the development and distribution of various medicinal products. Venmax Drugs & Pharmaceuticals is privately held and operates in Biotechnology.
When did Venmax Drugs & Pharmaceuticals acquire Hatri Pharma Private Limited?
Venmax Drugs & Pharmaceuticals's acquisition of Hatri Pharma Private Limited was reported on September 8, 2026. Venmax Drugs & Pharmaceuticals has scheduled a shareholder meeting on October 24, 2026, to discuss its proposed merger with Hatri Pharma Private Limited. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Hatri Pharma Private Limited do?
Hatri Pharma Private Limited is a pharmaceutical company engaged in developing healthcare solutions. The firm focuses on quality and efficacy in its product offerings. It aims to enhance its capabilities through strategic partnerships and amalgamations. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.